Arrowhead Pharmaceuticals today announced results from studies of ARC-520, a prior-generation RNAi therapeutic candidate against chronic hepatitis B virus (HBV) infection, in a Phase 2 clinical study in HBV patients and a ...
Sep 27, 2017
0
3
(HealthDay)—For hepatitis B virus (HBV) carriers, hepatitis B virus core-related antigen (HBcrAg) levels are associated with progression to cirrhosis, according to a study published online Sept. 15 in the Journal of Gastroenterology ...
Sep 21, 2017
0
0
Public health authorities on Tuesday declared an outbreak of the highly contagious liver disease hepatitis A in Los Angeles County, the third California region to see significant infections this year.
Sep 19, 2017
0
0
(HealthDay)—Non-specialists, including primary care providers (PCPs) and nurse practitioners (NPs), safely and effectively administer direct-acting antiviral therapy for hepatitis C virus (HCV) to patients seen in federally ...
Aug 8, 2017
0
0
(HealthDay)—More interventions are needed to meet the target of hepatitis C virus (HCV) elimination, defined as a 90 percent reduction in prevalence by 2020, in the country of Georgia, according to research published in ...
Jul 31, 2017
0
0
(HealthDay)—For patients in an urban clinic with hepatitis C virus (HCV) with HIV coinfection, HCV treatment is effective with standardized nurse/pharmacist support, according to a study published online June 13 in Hepatology.
Jun 16, 2017
0
0
Globally, an estimated 71 million people are living with chronic hepatitis C virus (HCV). Over decades of infection, chronic HCV infection results in progressive damage to the liver and an increased risk for end stage liver ...
Jun 8, 2017
0
20
Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and ...
May 11, 2017
0
2
Researchers at UCSF and their colleagues have found that hepatitis C virus (HCV) infection among people who inject drugs remains high and stable in some North American cities but incidence has dropped and remained low in ...
May 8, 2017
0
0
(HealthDay)—Hepatitis B virus (HBV) reactivation (HBV-R) is a safety concern for patients with HBV and hepatitis C virus (HCV) coinfection receiving direct-acting antiviral agents (DAAs), according to a study published ...
Apr 25, 2017
0
0
